Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001802768-25-000012
Filing Date
2025-02-18
Accepted
2025-02-18 17:16:26
Documents
1
Period of Report
2025-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1739916980.html 4  
1 FORM 4 wk-form4_1739916980.xml 4 7544
  Complete submission text file 0001802768-25-000012.txt   8968
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Issuer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Hite Christopher (Reporting) CIK: 0001814238 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39329 | Film No.: 25636133